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TObjective: Animal studies have shown that pretreatment with hyperbaric oxygen can
induce central nervous system ischemic tolerance and also modulate the inflammatory
response. We evaluated this therapy in patients undergoing cardiopulmonary bypass.
Methods: Sixty-four patients were prospectively randomized to group A (n  31;
atmospheric air, 1.5 atmospheres absolute) or group B (n 33; hyperbaric oxygen, 2.4
atmospheres absolute) before on-pump coronary artery bypass grafting. Age, sex, body
mass index, diabetes, hypertension, smoking, coronary disease severity, left ventricular
function, Parsonnet score, Euroscore, bypass time, myocardial ischemia time, and
number of grafts were comparable in both groups. Canadian Cardiovascular Society
angina, New York Heart Association dyspnea, and previous myocardial infarction were
significantly higher in group B. Inflammatory markers were analyzed before surgery and
2 and 24 hours after bypass. Neuropsychometric testing was performed 48 hours before
surgery and 4 months after surgery and included trail making A and B, the Rey auditory
verbal learning test, grooved peg board, information processing table A, and digit span
forward and backward. Neuropsychometric dysfunction was defined as more than 1 SD
deterioration in more than 2 neuropsychometric tests. Chi-square tests, Fisher tests, t
tests, and analysis of variance were used as appropriate for statistical analysis.
Results: Group A had a significant postoperative increase in the inflammatory markers
soluble E-selectin, CD18, and heat shock protein 70. This was not observed in group B.
Neuropsychometric dysfunction was also significantly higher in group A compared with
group B. There was no difference in any other early postoperative clinical outcome.
Conclusions: Our results seem to indicate that pretreatment with hyperbaric oxygen can
reduce neuropsychometric dysfunction and also modulate the inflammatory response
after cardiopulmonary bypass. However, further multicenter randomized trials are
needed to clinically evaluate this form of therapy.
Despite advances in surgical technique and bypass technology, there is a highincidence of neuropsychometric dysfunction and systemic inflammatory re-sponse after cardiac operations. Irrespective of the cause of injury, inflam-
matory cytokines released after the primary event trigger leukocyte activation and
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sion of injury. Thus, modulating inflammatory molecules
has the potential benefit of limiting leukocyte-mediated
extension of injury. This was exemplified in animal exper-
iments in which a reduction in cortical infarct size after
ischemic injury was noted with inhibition of adhesion mol-
ecules.1-4
Currently, hyperbaric oxygen is used as adjunctive therapy
to treat ischemic, traumatic, air-embolic, carbon monoxide–
induced, and radiation-induced brain injury. Although thus far
limited to postinjury treatment, experimental animal studies
have revealed that pretreatment5-8 with hyperbaric oxygen
can induce central nervous system ischemic tolerance and
reduce infarct volume and functional deficit. Both animal
and human studies have shown that the modality reduces
leukocyte sequestration,9,10 tumor necrosis factor (TNF)-
,10-13 interleukin (IL)-6,13 intercellular adhesion molecule
(ICAM)-1,14,15 CD18,16,17 tissue myeloperoxidase,18,19 and
lipid peroxidation20 during inflammation. The aim of our
study was to investigate whether these beneficial effects
could be applied to patients undergoing cardiopulmonary
bypass.
Materials and Methods
Ethics approval was obtained from the local regional ethics com-
mittee and the National Health Service research and development
department of the hospital before this prospective randomized
double-blind study was started. From January 2003 to January
2004, 64 patients scheduled to undergo on-pump coronary revas-
cularization were recruited for the trial. Exclusion criteria included
emergency operation, age older than 80 years, previous cerebro-
vascular disease, poor English language skills, learning difficulty,
visual or hearing impairment, claustrophobia, history of pneumo-
thorax, middle ear disease, and immunosuppressive or steroid
therapy. After fully informed voluntary consent, patients were
randomized either to the control group (group A) or to the hyper-
baric oxygen group (group B) by using computer-generated ran-
domization. The overall recruitment rate was 83.9%, and there
were no crossovers between the 2 groups.
Patients in both groups had 3 sessions in the hyperbaric cham-
ber 24, 12, and 4 hours before cardiopulmonary bypass. The
session sequence for group A consisted of slow pressurization over
Abbreviations and Acronyms
ATA  atmospheres absolute
HADS  hospital anxiety and depression scale
HSP  heat shock protein
ICAM  intercellular adhesion molecule
IL  interleukin
TNF  tumor necrosis factor
sE-selectin  soluble E-selectin
sP-selectin  soluble P-selectin10 minutes to 1.5 atmospheres absolute (ATA), 30 minutes in a
1624 The Journal of Thoracic and Cardiovascular Surgery ● Decclear plastic hood supplying atmospheric air, and 5 minutes out of
the hood, followed by a further 30 minutes back in the hood, at the
end of which slow depressurization over 25 minutes to 1 ATA
(normal atmospheric pressure) was accomplished. The session
sequence for group B consisted of slow pressurization over 10
minutes to 2.4 ATA, 30 minutes in a clear plastic hood supplying
100% oxygen, and 5 minutes out of the hood, followed by a further
30 minutes back in the hood, at the end of which slow depressur-
ization over 25 minutes to 1 ATA was accomplished. The pressure
and duration for each group was based on the optimum effect
noted in previous studies9-19 and patient safety considerations. The
anesthetic, bypass, and operative techniques were standardized in
all patients. Intermittent fibrillatory arrest was used for myocardial
protection. A Stockert SIII roller pump (Stöckert Instrumente
GmbH, Munich, Germany) with a hollow-fiber membrane oxygen-
ator with an integral hard shell venous cardiotomy reservoir
(Avant Phisio/M; Dideco SpA, Mirandola, Italy) was used for
cardiopulmonary bypass. A 38-m arterial line filter (Affinity352;
Medtronic, Inc, Minneapolis, Minn) was used in all cases. Mod-
erate systemic hypothermia of 35°C was maintained during by-
pass, and rewarming was commenced during the last bottom-end
anastomosis.
The laboratory analysis of inflammatory markers was per-
formed by immunologists at the Department of Immunology,
University of Hull, who were blinded to the groups. Markers of
inflammatory response measured included cytokines (TNF-,
IL-6, and IL-8), soluble adhesion molecules (soluble E-selectin
[sE-selectin], soluble P-selectin [sP-selectin], and soluble ICAM-
1), the leukocyte-bound adhesion molecule CD18, and the stress
response protein heat shock protein (HSP)-70. Blood for analysis
was drawn from the central venous line at 3 time points: before
skin incision and 2 and 24 hours after cardiopulmonary bypass.
Quantitative enzyme-linked immunosorbent assay was used for
measuring IL-6 (KAC1261; BioSource International Inc, Cama-
rillo, Calif), IL-8 (KAC1301; BioSource International Inc), TNF-
(KAC1751; BioSource International Inc), sE-selectin (KHS2011;
BioSource International Inc), sP-selectin (KHS2021; BioSource
International Inc), soluble ICAM-1 (KHS5411; BioSource Inter-
national Inc), and HSP-70 (EKS-700; Stressgen Biotechnologies
Corporation, Victoria, British Columbia, Canada). An Anthos
2010 microtiter plate reader (Anthos Labtec Instruments GmbH,
Wals, Austria) was used for the spectrophotometric measurement
with Stingray software (Stingray Software Inc, Devon, United
Kingdom) for analyses. Fluorescein-tagged anti-human CD18 an-
tibodies (MCA503; Serotec Ltd, Kidlington, Oxfordshire, United
Kingdom) were used for quantitative flow cytometric estimation of
leukocyte CD18 by using a BD FACSCalibur analyzer (BD Bio-
sciences Pharmingen, San Diego, Calif) with CellQuest software
(BD Biosciences). To eliminate the effect of hemodilution caused
by the priming solution in the pump and from intravenous fluids
administered during and after surgery, the actual measured plasma
levels of inflammatory molecules at 2 and 24 hours after bypass
were multiplied by the correction factor described by Roth-Isigkeit
and associates.20
Correction factor phctti ⁄ phctt0,where phct indicates plasma hematocrit (100  red blood cell
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EThematocrit percentage), ti indicates the value at the time of sam-
pling, and t0 indicates the value at baseline.
Neuropsychometric assessment was performed by neuropsy-
chologists at the Department of Neuropsychology, University of
TABLE 1. Comparison of demographic and perioperative
factors
Variable Group A Group B P value
Age 65.9 1.7 66.2 1.5 .9
Sex
Male 83.9% 87.5% .7
Female 16.1% 12.5%
Body mass index (kg/m2) 26.7 0.6 27.3 0.8 .5
Unstable angina 6.5% 6.3% .9
Previous myocardial infarction 9.7% 31.3% .03
Left main stem disease 29% 18.8% .3
Coronary disease severity
Single 12.9% 3.1%
Double 32.3% 21.9%
Triple 54.8% 75% .2
Left ventricular function
Good 87.1% 81.2%
Moderate 9.7% 12.5%
Poor 3.2% 6.3% .9
Hypertension 67.7% 62.5% .7
Diabetes mellitus 12.9% 15.6% .8
Peripheral vascular disease 6.3% 6.1% .9
Parsonnet score 6.5 1.2 7.2 1 .6
EuroSCORE 3.3 0.4 3.5 0.3 .7
No. of grafts
1 16.1% 0
2 35.5% 37.5%
3 48.4% 62.5% .07
Myocardial ischemia time
(min)
23.5 1.5 24.8 1.4 .5
Cardiopulmonary bypass time
(min)
50.1 4.3 52.1 3 .7
CVA/TIA 0 0
Mortality 0 0
Neuropsychometric test-retest
interval (d)
120.1 3.6 126.3 4.3 .3
Verbal IQ: WTAR standardized
score
101.3 2.8 95.8 2.9 .2
Nonverbal IQ: Raven matrices 29.7 0.7 30.1 0.8 .7
Preoperative (HADS) anxiety
score
6.7  0.8 5.6 0.8 .3
Postoperative (HADS) anxiety
score
4.9  0.6 4.6 0.6 .7
Preoperative (HADS)
depression score
4.6  0.6 3.2 0.4 .1
Postoperative (HADS)
depression score
3.3  0.5 2.3 0.4 .2
Data are mean  SE unless otherwise noted. CVA, Cerebrovascular
accident; TIA, transient ischemic attack; WTAR, Wechsler Test of Adult
Reading; HADS, hospital anxiety and depression scale.Hull, who were blinded to the groups. All the recommendations on
The Journal of Thoracicconducting neuropsychometric assessment issued by the 1994 con-
ference on central nervous system dysfunction after cardiac sur-
gery21 were followed. The assessments were performed 48 hours
before surgery and approximately 4 months after surgery. The
Wechsler Test of Adult Reading and Raven colored progressive
matrices were used to assess verbal and nonverbal IQ, respec-
tively, during preoperative testing. The self-reported hospital anx-
iety and depression scale (HADS) was used for mood assessment
before both preoperative and postoperative assessment. The 7-test
neuropsychometric assessment battery included the adult memory
and information-processing table A, digit span forward, and digit
span backward, in addition to the 4 recommended21 core tests (trail
making A, trail making B, grooved peg board, and the Rey
auditory verbal learning test).
SPSS version 11 for Windows (SPSS Inc, Chicago, Ill) was
used for statistical analysis. Demographic and perioperative data
were analyzed by using the unpaired t test for continuous variables
and the 2 or Fisher test, as appropriate, for discrete variables.
Nonparametric analysis of variance was used to compare sequen-
tial change during the 3 time points for inflammatory markers.
Spearman correlation analysis of postoperative increases in in-
flammatory markers with age, duration of cardiopulmonary by-
pass, and duration of myocardial ischemia was also performed.
The standard deviation index method was used to analyze neuro-
psychometric outcome. This was one of the methods recom-
mended by the 1994 conference21 and has been validated by
previous studies.22,23 A postoperative deterioration of greater than
1 SD from the preoperative score in 2 or more tests (28% of the
tests) was considered significant neuropsychometric impairment.
For the peg board test with 2 subtests, a 1 SD decline in either of
the subtests was considered significant, whereas for the Rey Au-
ditory Verbal Learning Test, a 1 SD decline in any 2 or more of the
4 subtests was considered significant. The 2 test was used to
compare the 2 groups for statistical significance. Logistic regres-
sion analysis on the pooled data was performed to see whether we
could identify any predictors of neuropsychometric dysfunction.
Results
Both groups were comparable (Table 1) in terms of age, sex
ratio, body mass index, unstable angina, coronary disease
severity, left ventricular function, hypertension, diabetes
mellitus, peripheral vascular disease, Parsonnet score, Eu-
roscore, number of grafts, cardiopulmonary bypass time,
and myocardial ischemia time. Significantly more patients
(31.3%) in group B had previous myocardial infarction
compared with group A (9.7%). The postoperative trends in
inflammatory mediators are depicted in Table 2. Levels of
sE-selectin, IL-6, IL-8, CD18, TNF-, and HSP-70 peaked
at 2 hours and declined at 24 hours. The sP selectin level
showed a declining trend, whereas ICAM-1 initially de-
clined at 2 hours before reaching preoperative levels at 24
hours. Analysis of variance revealed a significant postoper-
ative increase in sE-selectin (P  .05), CD18 (P  .001),
and HSP-70 (P  .007) in group A that was not seen in
group B (P  .2, P  .1, and P  .2, respectively). The
postoperative increase in IL-6, IL-8, ICAM-1, and TNF-
and Cardiovascular Surgery ● Volume 130, Number 6 1625
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was not significant in either group. Spearman correlation
analysis (Table 2) revealed a significant direct correlation
between the postoperative increase in HSP-70 and the du-
ration of cardiopulmonary bypass (P .02) and myocardial
ischemia (P  .006). Such a correlation was not noted with
the rest of the inflammatory molecules.
The test-retest interval, verbal (Wechsler Test of Adult
Reading score) and nonverbal (Raven matrices) IQ, and
HADS results were comparable (Table 1). Table 3 shows
the group mean scores and standard deviations in individual
neuropsychometric tests and the deterioration in perfor-
mance using the standard deviation index method. A total of
16 patients in group A had significant neuropsychometric
dysfunction, compared with 9 patients in group B (P .05).
TABLE 2. Comparison of inflammatory markers and correl
monary bypass time, and myocardial ischemia time
Variable
Group A
Preop
2 h after
bypass
24 h after
bypass
P
value Preop
sE-selectin .05
Mean  SE 23.2  2.4 36.9  6.4 24  3.6 30.9  3.
Interquartile
range
14.9–33.1 21.6–40 16.6–27.8 14.9–37.2
sP-selectin .1
Mean  SE 180.6  22.1 172  25.2 121.8  13 208.5  30
Interquartile
range
102–224.4 91.3–193.3 82.4–157.4 95.8–282.
IL-6 .0001
Mean  SE 3 1.1 76.5  6.4 76.9  5.7 3.2  1
Interquartile
range
0.3–2.7 38.4–100 56.7–100 0.4–2.6
IL-8 .0001
Mean  SE 11.6  2 61.9  11.4 22.3  13.2 8.6  1.
Interquartile
range
5.2–13.5 23.97–93.6 12.9–27.9 2.4–10.4
ICAM-1 .02
Mean  SE 342.2  26 267.2  15.5 336.1  18.2 372.2  23
Interquartile
range
219.1–421 214.1–329.4 258.7–414.6 277.7–471
CD18 .001
Mean  SE 63.6  3.6 83.8  3.4 80.5  4.7 63.3  4.
Interquartile
range
49.5–80.3 66.6–96.6 60.3–95.1 47.2–81.2
TNF- .0001
Mean  SE 21.1  2.5 47.3  7.1 22.4  3 27.5  3.
Interquartile
range
13.8–25.7 22.4–63.7 14.3–28.1 18.3–32.7
HSP-70 .007
Mean  SE 8.1  1 19.7  4.5 8.9  1 7.6  1.
Interquartile
range
6.1–9.2 11.8–33.8 6.7–10.3 5–10.2
Preop, Preoperative; CPB, cardiopulmonary bypass; CCE, correlation coeffic
ICAM, intercellular adhesion molecule; TNF, tumor necrosis factor; HSP, heaNone of the tested variables—age, sex, left ventricular
1626 The Journal of Thoracic and Cardiovascular Surgery ● Decfunction, cardiopulmonary bypass time, myocardial isch-
emia time, verbal and nonverbal IQ, HADS results, or
postoperative increase in inflammatory markers—were pre-
dictors of neuropsychometric decline on logistic regression
analysis.
Discussion
Coronary artery bypass surgery is one of the most fre-
quently performed operations worldwide. Despite advances,
there is still a significant risk of brain injury inherent to the
procedure. In addition, the inflammatory response plays an
important role in progressive organ damage and periopera-
tive morbidity. Hyperbaric oxygen has been shown to in-
duce central nervous system ischemic tolerance5-8 in animal
studies and also to reduce the inflammatory response9-19 in
analysis of postoperative increase with age, cardiopul-
Group B Age CPB time
Myocardial
ischemia
time
h after
bypass
24 h after
bypass
P
value CCE
P
value CCE
P
value CCE
P
value
.2 0.1 .4 0.2 .3 0.2 .1
3.2  5.4 34.4  4.4
22–61.3 15.5–53.6
.1 0.2 .2 0.1 .4 0.1 .5
8.5  32.7 135.6  21.2
4.6–242.8 55.4–171.3
.0001 0.1 .3 0.1 .3 0.2 .4
1.8  6.1 68.7  5.9
76.5–100 51.9–100
.0001 0.1 .4 0.04 .8 0.1 .6
0.3  9.2 24.2  2.2
0.5–72.4 14.5–35.1
.01 0.1 .3 0.2 .3 0.05 .7
4.3  22.6 431.4  42
4.6–362.2 279.5–522.2
.1 0.009 .9 0.2 .1 0.2 .2
7.5  4.7 71.9  4.8
8.5–93.7 46.6–91.8
.001 0.005 .9 0.1 .3 0.2 .1
4.8  9.3 26.4  3.1
1.1–78.7 18.5–34.8
.2 0.1 .7 0.6 .02 0.7 .006
14  2.8 11.9  2
6.8–21 7.3–16.1
E-selectin, soluble E-selectin; sP-selectin, soluble P-selectin; IL, interleukin;
k protein.ation
2
9 4
20
8 8
8
4 6
3
.8 29
21
1 7
5
4 5
2
4
ient; sanimal and human studies. Although the precise mechanism
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ETof action is still unclear and continues to be investigated, the
purported effectiveness and relative safety of the modality
makes it potentially applicable in cardiac surgery.
We performed a broad analysis of cytokines, adhesion
molecules, and stress response proteins to gain an insight
into the induction, propagation, and stress response phases of
the inflammatory cascade. The selection of markers was also
based on a review of the published literature9-19 and the avail-
ability, reproducibility, sensitivity, specificity, and cost-effec-
tiveness of the tests. The main difference between this study
and previously published work using hyperbaric oxygen as
TABLE 3. Comparison of neuropsychometric test performa
Neuropsychometric tests
Group A
Preop score Postop scor
Trail making A
Mean  SD 41.7  14.9 40.6 15.
Interquartile range 30.5–55 30–47.5
Trail making B
Mean  SE 101  43.5 107 54.
Interquartile range 67–109.5 69–132.5
Grooved pegboard, dominant hand
Mean  SE 19.1  2.2 19.1 2.6
Interquartile range Grooved
pegboard, nondominant hand
17.5–20.9 17–20.9
Mean  SE 21 2.3 20.4 2.6
Interquartile range 19.1–22.5 18.5–21.9
Rey auditory verbal learning test
Total recall (attempts 1-5)
Mean  SE 41.2  9.6 40.6 10.
Interquartile range 34.5–47.5 33–48.5
Immediate recall
Mean  SE 8.1 3.3 7.8 3
Interquartile range 5–11 5–10
Delayed recall
Mean  SE 8.4 3.5 7.7 3
Interquartile range 6–12 5–10
Recognition
Mean  SE 11.8  2.8 12.1 2.3
Interquartile range 10–14.8 11–13.8
Adult memory and information
processing, Table A
Mean  SE 59 14.6 61.1 15.
Interquartile range 48–69.5 49–73.5
Digit span forward
Mean  SE 9.9 2.7 9.5 2.6
Interquartile range 7.3–12 8–11
Digit span backward
Mean  SE 6.8 2.5 6.3 2.2
Interquartile range 5–8.8 5–8
Significant neuropsychometric dysfunction (1 SD decline in 2 tests) o
Preoperative; Postop, postoperative.a modulator of inflammatory response is that our main
The Journal of Thoracictrigger for inflammation was extracorporeal circulation and not
sepsis, shock, or ischemia. Species-specific differences, trig-
ger-specific variation in inflammatory response within the
same species,24,25 and the effects of medications such as aspi-
rin,26 statins,27 and angiotensin-converting enzyme inhibi-
tors28 are potential reasons why the trend in certain markers
such as CD18 correlated with the findings of previous work,
whereas others, such as TNF-, IL-6, and ICAM-1, did not.
Despite the significantly higher postoperative levels in sE-
selectin, CD18, and HSP-70 in group A, the overall trend in
the rise and fall of all the measured markers was similar in
Group B
Patients with
>1 SD
decline Preop score Postop score
Patients with
>1 SD
decline
2 4
43 16.3 41.4 15.5
31–50 29.8–55.3
3 2
127.1 52.6 108.7 45.5
89.3–158.5 69.5–134
6 4
19.7 2.8 19.1 2.5
17.5–21.6 17–20
21.1 3 20.9  3.7
18.8–22 19–23
19 10
37.8 11.5 39.4 11
29–47.3 32–45.3
7.5 2.7 7.5  3.5
6–8.3 6–10.3
7.6 3.6 7.9  3.2
5–9.3 5.8–10.3
11.4 2.7 12.4 1.9
10–14 11–14
3 4
52.9 15.8 55.5 13.7
43–61 47.5–60.5
6 5
8.9 2.3 9.2  2.5
7.8–11 7.8–11
10 5
5.9 2.1 6.1  2.1
4.8–7 5–8
ed in 16 patients in group A and 9 patients in group B (P  .05). Preop,nce
e
7
7
4
1
ccurrboth groups. Thus, the effect of hyperbaric oxygen was
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sponse—not annulling it. The significant correlation be-
tween HSP-70, cardiopulmonary bypass time, and myocar-
dial ischemia time is consistent with the acute stress
response nature of the protein.29,30
Analyzing the dive pressures used in the study, it is clear
that group A was not a true placebo because the oxygen
percentage in air at 1.5 ATA pressure is equivalent to 30%.
However, this was a necessary compromise to preserve the
double-blind nature of the trial. The slightly higher than
atmospheric pressure was necessary so that patients in the
control group heard pressurization sounds and felt ear pres-
sure changes similar to those that patients in group B heard
and felt. If we had used diluted air to make a true placebo,
ie, patient breathing 21% oxygen at 1.5 ATA, then the
increase in nitrogen in the air mix would certainly increase
the risk of decompression illness. This was minimized by
the safe protocol we used, ie, true air at depth. Of impor-
tance is the absence of any significant effect on infarct
volume5-8 and inflammatory mediators9-19 by air at less than
2 ATA noted in previous studies.
Neuropsychometric examination is a time-tested method
of identifying cognitive dysfunction resulting from brain
injury. Despite the advent of functional magnetic resonance
imaging scanning, when performed by trained individuals,
neuropsychometric examination is still a reliable and repro-
ducible way of identifying, assessing, and measuring brain
injury. In choosing the neuropsychometric test battery, our
aim was to perform a global assessment of different do-
mains within an optimum time period without mentally
fatiguing the patient. The main problem during analysis and
interpretation of the neuropsychometric test results of a
group is the effect of practice and learning during repeat
testing. Just like the proportion of patients whose perfor-
mance and scores decline, a proportion of patients will do
the opposite and score higher. Although by using alternate
forms of the same test and limiting the number of repeat
tests, this practice effect can be reduced, it cannot be com-
pletely eliminated. This effect becomes evident on compar-
ing the group means (Table 3): in the Trail Making B test,
there was a significant improvement in group B (P  .01)
performance, compared with a deterioration in group A
(P  .4). Comparing the overall group mean loses its rele-
vance in a study aimed at preventing or reducing neuropsy-
chometric decline. We used the standard deviation index
method to exclude the effect of this phenomenon. Using this
method, we found that significantly (P .05) more patients in
group A had neuropsychometric impairment compared with
group B (Table 3). None of the tested variables—age, sex, left
ventricular function, cardiopulmonary bypass time, myocardial
ischemia time, IQ, mood, or postoperative increase in inflam-
matory markers—was a predictor of neuropsychometric de-
cline on logistic regression analysis.
1628 The Journal of Thoracic and Cardiovascular Surgery ● DecThe main limitation of this study is that it was based on
a small sample of low-risk patients at a single center.
Arguably this allows reproducibility, and one cannot gen-
eralize the findings of this study. Only a prospective ran-
domized controlled multicenter trial would provide the so-
lution to this argument. The operative and perioperative
factors were standardized as much as possible; however,
one factor that could have a bearing on neuropsychometric
outcome is the distribution of atherosclerotic plaques within
the ascending aorta. Patients with peripheral vascular dis-
ease were excluded from the study, and the surgeons exter-
nally palpated the aorta and avoided any areas of plaque
during clamping of the aorta; however, this is not a fool-
proof method. Perhaps epiaortic Doppler scanning or trans-
esophageal echocardiography would have been a better way
of detecting aortic atherosclerosis. We performed only a
single postoperative neuropsychometric assessment at 4
months. This was to minimize the practice effect, exclude
the effect of postoperative recovery and medications on
early assessment, and exclude the effect of new but unre-
lated cerebral events on delayed assessment. Despite stan-
dardization of the anesthetic techniques and drugs used,
possible variations in dosage, patient metabolism, and elim-
ination of the different drugs are inevitable. The time lapse
between operation and assessment would have certainly
allowed for any direct cerebral effects of the anesthetic
medications to be eliminated. Although the outcome at 4
months is an indication of the long-term neuropsychometric
dysfunction, it may not necessarily reflect permanent se-
quelae from the initial brain injury. Of importance is the fact
that any human study of this nature precludes neuronal
evaluation. Enzyme induction or inhibition, free radical
release, antioxidant status, and protein synthesis are ill-
understood aspects of the mechanism of action that can be
evaluated only through in vitro studies or animal models.
This was one of the first human trials of this nature, and
further prospective randomized multicenter trials are neces-
sary to confirm the findings of this study. The cost of 1
hyperbaric oxygen treatment session was £50, and our use of 3
sessions was based on previous animal studies; however, if
further trials reveal a consistent effect with 1 session, the
technique becomes more cost-effective and clinically feasible
in high-risk cases. Neuropsychometric dysfunction does not
necessarily prolong hospitalization or add to the immediate
cost of treatment, but it has a considerable effect on a
patient’s memory, behavior, interactive ability, and socio-
economic circumstances.
In conclusion, although this study revealed that pretreat-
ing patients with hyperbaric oxygen reduces the postopera-
tive inflammatory response and neuropsychometric dys-
function, the actual mechanism underlying this beneficial
effect is still unclear. Pursuing cellular-level changes in
enzyme induction or inhibition, free radical release or inhi-
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ETbition, antioxidant status, and protein synthesis may hold
the answer and is an area for further research.
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Discussion
Dr William A. Baumgartner (Baltimore, Md). I congratulate Mr
Alex and his associates for conducting a randomized prospective
double-blind study evaluating the use of hyperbaric oxygen and its
efficacy in reducing neurocognitive dysfunction after cardiopul-
monary bypass. As he mentioned, the patients, surgeons, and
neuropsychologists were all blinded to the study groups. The
results are fairly straightforward in that there was no significant
difference in any clinical postoperative variable other than neuro-
cognitive dysfunction, which was significantly better in the pa-
tients who received hyperbaric oxygen treatment. There is a grow-
ing body of both experimental and some clinical studies, as pointed
out by the authors, using hyperbaric oxygenation to reduce partic-
ularly focal cerebral ischemia associated with a stroke. This area of
research has been somewhat controversial for a number of years.
One of the potential beneficial mechanisms of action of
hyperbaric oxygen is the reduction in the inflammatory re-
sponse. Although you showed a statistical reduction in a few
markers in the treated group, many markers showed no change
and Cardiovascular Surgery ● Volume 130, Number 6 1629
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the primary neuroprotectant mechanism associated with hyper-
baric oxygen?
We and now others have demonstrated by using a controlled
cohort of patients with similar risk factors that there does not
seem to be any significant difference in the incidence of neu-
rocognitive decline at 3 months or at 1 year, and now recently
3 years, between patients undergoing traditional coronary artery
bypass grafting with the pump and those control patients who
had undergone catheterization and/or angioplasty. This suggests
that the decline may be more associated with cardiac risk
factors rather than an operation which occurred a year ago.
Would you please speculate and comment on using a control
group of patients with similar risk factors who could undergo
hyperbaric oxygen treatment but no operation and subsequent
study 4 months later?
I was also wondering, since limiting aortic manipulation has
been targeted as a potential method to reduce neurologic injury,
was there a difference between groups as to the number of times
the aorta was manipulated with the clamp?
Once again, I congratulate the authors for carrying out a ran-
domized controlled double-blinded study and agree with them that
further studies are needed to help define the efficacy of hyperbaric
oxygen treatment.
Mr Alex. Coming to the first question, as mentioned in the
presentation, following ischemia, extension of an infarct is medi-
ated to a significant extent by leukocyte addition, degranulation,
and free radical release. The mechanism of hyperbaric neuropro-
tection seems to be 2-pronged in limiting the leukocyte endothelial
addition and, on the other side, augmenting antioxidant defenses.
Though we showed a reduction in soluble E-selectin and CD18,
consistent animal data and human data have shown that other
studies have seen a reduction in the other inflammatory molecules
that we analyzed, soluble ICAM-1 and P-selectin, and also the
inflammatory markers IL-6, IL-8, and TNF-. The modality also
augments superoxide dismutase levels and inhibits neuronal nitric
oxide synthetase.
Regarding the second query, yes, these are the preliminary results
of an ongoing trial, and the phase II trial includes 3 additional groups:
a nonsurgical noncardiac group, a nonsurgical cardiac group, and a
noncardiac general surgical group, each matched.
Going back to the point of neurocognitive dysfunction, there
are 2 aspects of brain injury, the quantitative and the functional
aspects. Transcranial Doppler and magnetic resonance imaging scans
have shown that quantitatively there is an increase in microembolic
load and microinfarct, cortical microinfarct, following the procedure,
and subsequent studies have shown a coordination between the mag-
nitude of the microemboli and cortical infarcts to subsequent early
neurocognitive dysfunction in these patients.
Though neurocognitive dysfunction measures neurocognitive
assessment, though it measures the functional aspect, it does not
account for the compensation by the normal cortex for subcritical
ischemic infarcts. For want of a better end point, we used neuro-
cognitive assessment in this trial to test whether the modality
would improve the outcome following brain injury.
Coming to the third point, yes, aortic manipulation was
different between the 2 groups. The hyperbaric group, in fact,
1630 The Journal of Thoracic and Cardiovascular Surgery ● Dechad a higher number of grafts, 3 grafts; 63% in the hyperbaric
group had 3 grafts, compared to 43%. Given the technique we
used, which was crossclamp fibrillation, aortic manipulation
was definitely higher. And 16% of the patients in the control
group had single grafts, which were basically left internal
thoracic artery to left anterior descending artery, which did not
need aortic side clamp application.
Dr Richard Anderson (Seattle, Wash). My institution in
Seattle has recently expanded its hyperbaric capability, and I
am sure that those involved will be very pleased to read your
paper when it comes out. There are skeptics that still say that
this is a therapy in pursuit of a disease, but I hope you are right.
I do have one concern. Some years ago, Alan Hall, one of
my colleagues, did a study of neurocognitive function accom-
panied by brain scans before and after operation, and amongst
the interesting observations in this study was the fact that in
otherwise cognitively normal individuals preoperatively, there
are often a number of abnormalities that are noted in the brain
scan. Now, in some individuals, these increase following sur-
gery, as you would expect from the small embolic consequences
and so forth, but the other observation was that regardless of the
changes postoperatively in the brain scan, those individuals
with abnormal studies preoperatively showed the largest cog-
nitive declines in postoperative study.
So my question to you is, is it conceivable that failure to
control for an underlying structural abnormality in the brain
could have biased your study regardless of the fact that it was
a randomized study? And perhaps if you are going to continue
with these studies, is there some way to address this issue?
Mr Alex. Yes, we did exclude patients with a history of
cerebrovascular disease. This was basically because this was a
phase I trial, and the next phase includes patients who are at
high risk for neurocognitive dysfunction. That includes patients
with diabetes and hypertension, who were in this study, but also
patients with previous cerebrovascular accidents and carotid
artery disease. So we are in the process of addressing that.
Dr Hillel Laks (Los Angeles, Calif). I just wanted to recall the
experience that we had with Dr Bill Burnhart when I was a
resident, who was still doing closed heart procedures in a
hyperbaric chamber to try and prevent neurologic injury.
I had a question for you. Did you have the opportunity of treating
any patients postoperatively after they had a neurologic event, and is
there any evidence that this might improve the recovery?
Mr Alex. Certainly, since the trial we have treated 3 patients
so far, but these patients weren’t part of the trial. This was
based on the outcome of this trial, and their improvement was
definitely better. The mechanism for postoperative hyperbaric
treatment is slightly different from what the pre-treatment mo-
dality is. The normal soluble oxygen is about 0.3 mL/100 mL of
blood, whereas with hyperbaric oxygenation (at pressures used
in this study), this goes up to 6.8 mL/100 mL of blood. That is
the soluble oxygen in the plasma. This increases the tissue
penetration of oxygen, which appears to be one reason why
patients post infarct recover so quickly with this modality. Yes,
we have had patients who have been treated with hyperbaric
oxygen post infarct.
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